The IQMH office is closed to prevent the spread of COVID-19. We have moved to a virtual office. More info: IQMH Response to COVID-19.
One of the most significant changes in 2020 is the redesign of the Proficiency Testing (PT) Chemistry program. A summary of changes to the Serum and Urine Chemistry surveys can be seen in Table 1.
The first Urine Chemistry survey of the year is now closed, and completely redesigned survey reports will be provided to participants. An instruction document has been created to guide participants in interpreting the new survey reports. Participants are encouraged to read the document, Instruction - Interpretation of Proficiency Testing Survey Reports - CHEM, which is available in QView™.
Attention: Chemistry and Endocrinology Proficiency Testing (PT) Participants
IQMH is seeking a volunteer to sit on its Proficiency Testing Scientific Committee, effective January 1, 2020. Membership on committees consists of a three-year term of office, renewable once. Committees meet an average of four times a year for half-day or full-day meetings.
The release of the 2020 Proficiency Testing Programs included changes to the Chemistry survey. The new Serum Chemistry (CHEM) survey consists of analytes that were previously in the Routine Chemistry (CHEM), Drug Monitoring (DRUG), Enzymes and Bilirubin (ENZY), and Lipids (LIPS) surveys, except ethanol and tobramycin which have been removed from the program. The following new analytes have also been added: cholinesterase, CK-MB, fructosamine.
Participants can now customize their surveys according to their laboratory’s test menus (serum chemistry only). Choose from a large variety of analytes and pick from several price categories that suit your laboratory’s needs.
The American Association of Clinical Chemists’ Critical and Point-of-Care Testing Division and the International Federation of Clinical Chemistry and Laboratory Medicine held a symposium September 26–28 in Washington, D.C.: 27th International CPOCT Symposium: The Role of Point-of- Care Testing in the Value-Based Healthcare Landscape. The event was very informative with a focus on the current and future role of point-of-care testing (POCT) in a healthcare environment with an emphasis on value and quality of care.
By Julie Shaw, Danijela Konforte, Gayle Waite, and Paul Yip
Assays, especially those in clinical chemistry, are designed to measure analytes (i.e. the measurand) in the appropriate patient specimens. However, there is the potential for inaccurate analyte measurements when testing materials that are different from patient specimens. Examples include quality control (QC) material, proficiency testing (PT) material, and other types of patient specimens such as body fluids.
By: Lianna Kyriakopoulou, Tracy Wade and Paul Yip, on behalf of the IQMH Chemistry Scientific Committee
Bias is a significant challenge for clinical laboratories that perform numerous quantitative analyses on several analytes that have direct impact on clinical decision making.
The Ontario Society of Clinical Chemists (OSCC) and the Institute for Quality Management in Healthcare (IQMH) are collaborating once again to develop at two-day event focused on Evidenced-based Laboratory Medicine — Harmonization and Beyond.
Institute for Quality
Management in Healthcare
1500-393 University Avenue
Toronto, Ontario Canada M5G 1E6
Get industry news and event information:SUBSCRIBE